Key result
Rapid ultra-high-resolution mapping with Rhythmia resulted in similar freedom from AF/AT recurrence compared to point-by-point mapping with Carto (88.2% vs 84.8%, P=0.53).
Why the study?
Does rapid ultra-high-resolution mapping with the Rhythmia system improve procedural efficiency or clinical outcomes compared to point-by-point mapping with the Carto system in patients undergoing AF ablation?
Cohort (n=74)
Does rapid ultra-high-resolution mapping with the Rhythmia system improve procedural efficiency or clinical outcomes compared to point-by-point mapping with the Carto system in patients undergoing AF ablation?
Absolute Event Rate: 88.2% vs 84.8%
p-value: p=0.53
The Rhythmia ultra-high-resolution mapping system is effective for AF ablation with similar clinical outcomes to the established Carto system, despite longer mapping and fluoroscopy times.
Should not yet change AF ablation mapping choice; leaves open efficiency trade-offs in randomized trials.
INTRODUCTION: Three-dimensional electroanatomical mapping (EAM) is an established tool facilitating catheter ablation. In this context, the novel Rhythmia system sets a new bar in fast high-resolution mapping. The aim of this study was to directly compare point-by-point versus rapid ultra-high-resolution EAM in patients scheduled for ablation of atrial fibrillation (AF) with focus on procedural data, acute success, and midterm clinical outcome. METHODS AND RESULTS: A total number of 74 consecutive patients (48/74 male) with symptomatic AF were scheduled to undergo pulmonary vein isolation (PVI) using either Carto or Rhythmia. The Carto-guided procedures were performed using point-by-point acquisition according to our routine approach, whereas for Rhythmia, fast anatomical mapping was utilized. Comparing Rhythmia- versus Carto-guided ablation approaches, we observed a significantly longer total mapping time (P = 0.001), longer total fluoroscopy time (P = 0.001), more delivered RF-applications (P = 0.019), and longer total RF-duration (P = 0.002). There was no difference regarding total ablation time (P = 0.707), total procedure duration (P = 0.99), and acute procedural success. During follow-up, 84.8% of patients remained free from any AF/AT-recurrence using Carto versus 88.2% when using Rhythmia (P = 0.53). From Kaplan-Meier analysis, the event rate estimations were 15% versus 13.5%, respectively. CONCLUSION: The present study reports our first clinical experience using Rhythmia in direct comparison with the established Carto system for AF ablation. Our data clearly demonstrate that Rhythmia was proved to be effective and well applicable but more data will be mandatory before final conclusions can be drawn.
No takes yet. Share an insight, caveat, or question.
Rottner et al. (2017) conducted a cohort in Atrial fibrillation (n=74). Rhythmia rapid ultra-high-resolution electroanatomical mapping vs. Carto point-by-point electroanatomical mapping was evaluated on Freedom from any AF/AT-recurrence (p=0.53). Rapid ultra-high-resolution mapping with Rhythmia resulted in similar freedom from AF/AT recurrence compared to point-by-point mapping with Carto (88.2% vs 84.8%, P=0.53).